FDA Changes Position On Abortion Pill Access; Parties Seek Stay Of Appeal

(April 15, 2021, 2:01 PM EDT) -- RICHMOND, Va. — The Food and Drug Administration on April 13 asked the Fourth Circuit U.S. Court of Appeals to hold in abeyance its appeal involving the remote prescribing of the abortion pill mifepristone during the COVID-19 pandemic after the agency on April 12 changed its position on the issue....